Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07168356 · ClinicalTrials.gov registry record · Phase 1

A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

A Phase 1 study of Hepatitis B, sponsored by GlaxoSmithKline.

Recruiting
Registry status
Phase 1
Development phase
32
Enrollment target
1
Study location

NCT07168356 is a Phase 1 study of Hepatitis B that is actively recruiting participants, run by GlaxoSmithKline. The registered enrollment target is 32 participants, below the 1,628-participant average among 32 other Hepatitis B trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07168356, a Phase 1 study of Hepatitis B, is actively recruiting participants, sponsored by GlaxoSmithKline.

RECRUITING
Registry status
Phase 1
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This is a 2-part study where all participants will receive bepirovirsen. The study will measure how much bepirovirsen from a single dose gets into the blood, and how long it stays in the blood. The purpose of the study is to understand if blood levels of bepirovirsen are different in adults with kidney disease compared to healthy adults who do not have kidney disease.

Conditions Studied

Hepatitis B

Interventions

  • DRUG Bepirovirsen

Study Locations (1)

Florida

  • GSK Investigational Site - Tampa

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-09-16
Est. Completion 2026-08-18
Phase Phase 1

Sponsor

GlaxoSmithKline

1,345 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07168356

The ClinicalTrials.gov registry entry for NCT07168356 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,628-participant average among 32 other Hepatitis B trials with a reported enrollment target (98% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis B appearing as the primary indexed condition, and to 1 intervention - of which Bepirovirsen is the first listed.

NCT07168356 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07168356 about?

NCT07168356 is a clinical study titled "A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease". This is a 2-part study where all participants will receive bepirovirsen. The study will measure how much bepirovirsen from a single dose gets into the blood, and how long it stays in the blood. The purpose of the study is to understand if blood levels of bepirovirsen are different in adults with kid...

What is the current status of trial NCT07168356?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2025-09-16. Estimated completion is 2026-08-18.

What conditions does trial NCT07168356 study?

This clinical trial studies the following conditions: Hepatitis B.

What interventions are being tested in trial NCT07168356?

The interventions under investigation include: Bepirovirsen (DRUG).

Who is sponsoring clinical trial NCT07168356?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07168356 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis B

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis B

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.